Qiang Sa
YOU?
Author Swipe
View article: Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trial
Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trial Open
View article: Efficacy and safety of vascular-targeting agents in advanced soft tissue sarcoma: a systematic review and network meta-analysis
Efficacy and safety of vascular-targeting agents in advanced soft tissue sarcoma: a systematic review and network meta-analysis Open
Background: Soft tissue sarcomas (STS) are rare, heterogeneous tumors with poor prognosis, often characterized by high recurrence rates and limited response to conventional chemotherapy in advanced stages. Vascular-targeting agents (VTA) h…
View article: Clinicopathological Features and Prognostic Implications of HER2-Low in Early-Stage Male Breast Cancer: A Retrospective Analysis
Clinicopathological Features and Prognostic Implications of HER2-Low in Early-Stage Male Breast Cancer: A Retrospective Analysis Open
Background: The clinicopathological and prognostic features of HER2-low female breast cancer (BC) patients have been widely studied. Current knowledge suggests that low HER2 expression could be identified as a special entity for treatment.…
View article: Dynamic Hematological Indicators Predict the Efficacy of Cdk4/6 Inhibitors in Hr-Positive, Her2-Negative Metastatic Breast Cancer: An Exploratory Analysis of the Bright-2 Trial
Dynamic Hematological Indicators Predict the Efficacy of Cdk4/6 Inhibitors in Hr-Positive, Her2-Negative Metastatic Breast Cancer: An Exploratory Analysis of the Bright-2 Trial Open
View article: Development of graded prognostic assessment for breast Cancer brain metastasis incorporating extracranial metastatic features: a retrospective analysis of 284 patients
Development of graded prognostic assessment for breast Cancer brain metastasis incorporating extracranial metastatic features: a retrospective analysis of 284 patients Open
View article: The Impact of Extracranial Metastatic Features on Patients with Breast Cancer Brain Metastasis: A Retrospective Analysis of 284 Patients
The Impact of Extracranial Metastatic Features on Patients with Breast Cancer Brain Metastasis: A Retrospective Analysis of 284 Patients Open
Purpose Breast cancer brain metastasis (BCBM) is associated with poor survival outcomes and reduced quality of life. The Graded Prognostic Assessment (GPA) score model serves as a well-established tool for predicting the prognosis of BCBM.…
View article: New insights into HER2-low breast cancer brain metastasis: A retrospective analysis
New insights into HER2-low breast cancer brain metastasis: A retrospective analysis Open
Background: A considerable number of patients with breast cancer will suffer from brain metastasis in the advanced setting. The HER2 status serves as a significant prognostic factor and the reference of applying treatment for patients with…